In a filing, Finch Therapeutics Group Inc revealed its Director SMISEK JEFFERY A unloaded Company’s shares for reported $17070.0 on Mar 28 ’24. In the deal valued at $2.57 per share,6,642 shares were sold. As a result of this transaction, SMISEK JEFFERY A now holds 0 shares worth roughly $0.0.
Then, SMISEK JEFFERY A sold 1,600 shares, generating $4,176 in total proceeds. Upon selling the shares at $2.61, the Director now owns 6,512 shares.
Before that, SMISEK JEFFERY A sold 1,470 shares. Finch Therapeutics Group Inc shares valued at $5,351 were divested by the Director at a price of $3.64 per share. As a result of the transaction, SMISEK JEFFERY A now holds 6,642 shares, worth roughly $20590.2.
H.C. Wainwright initiated its Finch Therapeutics Group Inc [FNCH] rating to a Buy in a research note published on August 09, 2022; the price target was $17. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. Evercore ISI began covering FNCH with “an Outperform” recommendation on April 13, 2021. BofA Securities started covering the stock on April 13, 2021. It rated FNCH as “a Buy”.
Price Performance Review of FNCH
On Tuesday, Finch Therapeutics Group Inc [NASDAQ:FNCH] saw its stock jump 38.08% to $3.10. Over the last five days, the stock has gained 26.27%. Finch Therapeutics Group Inc shares have fallen nearly -14.13% since the year began. Nevertheless, the stocks have fallen -72.81% over the past one year. While a 52-week high of $16.74 was reached on 03/11/24, a 52-week low of $1.86 was recorded on 04/12/24. SMA at 50 days reached $2.56, while 200 days put it at $4.58. A total of 0.69 million shares were traded, compared to the trading of 19800.0 shares in the previous session.
Levels Of Support And Resistance For FNCH Stock
The 24-hour chart illustrates a support level at 2.35, which if violated will result in even more drops to 1.60. On the upside, there is a resistance level at 3.61. A further resistance level may holdings at 4.12. The Relative Strength Index (RSI) on the 14-day chart is 61.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 17.88%. Stochastics %K at 41.60% indicates the stock is a holding.
